Joint Commission of Pharmacy Practitioners

1

Academy of Managed Care Pharmacy

703-683-8416

Edith Rosato, Chief Executive Officer

American College of Apothecaries

901-383-8119

Ed Hesterlee, Executive Vice President

American College of Clinical Pharmacy

816-531-2177

Michael S. Maddux, Executive Director

American Pharmacists Association

202-628-4410

Thomas E. Menighan, Executive Vice President

American Society of Consultant Pharmacists

703-739-1300

Frank Grosso, Chief Executive Officer

American Society of Health-System Pharmacists

301-664-8890

Paul Abramowitz, Chief Executive Officer

National Community Pharmacists Association

703-683-8200

Douglas Hoey, Chief Executive Officer

Liaison Members

Accreditation Council for Pharmacy Education

312-664-3575

Peter H. Vlasses, Executive Director

American Association of Colleges of Pharmacy

703-739-2330

Lucinda L. Maine, Executive Vice President

National Alliance of State Pharmacy Associations

804-285-4431

Rebecca P. Snead, Executive Vice President

National Association of Boards of Pharmacy

847-391-4400

Carmen A. Catizone, Executive Director

1

Summary of Discussion –August 21, 2014

55 Attendees

Representing member organizations: (19)

Academy of Managed Care Pharmacy

Edith Rosato, Chief Executive Officer

Dana McCormick, President

Accreditation Council for Pharmacy Education

Peter Vlasses, Executive Director

Stephanie Gardner, President

American Association of Colleges of Pharmacy

Lucinda Maine, Executive Vice President

Pat Chase, President

American College of Apothecaries

Ed Hesterlee, Executive Vice President

American College of Clinical Pharmacy

Michael Maddux, Executive Director

Gary Yee, President

American Pharmacists Association

Thomas Menighan, Executive Vice President

Matt Osterhaus, President

American Society of Consultant Pharmacists

Frank Grosso, Chief Executive Officer

Jeffery Delafuente, President

American Society of Health-System Pharmacists

Paul Abramowitz, Chief Executive Officer

Christene Jolowsky, President

National Alliance of State Pharmacy Associations

Rebecca P. Snead, Executive Vice President

Phil Woodward, President

National Association of Boards of Pharmacy
National Community Pharmacists Association

Doug Hoey, Chief Executive Officer

Mark Riley, President

1

Guests

(36)

Joan Baird ((ASCP)

Lynne Batshon (ASCP)

Lynette Bradley-Baker (AACP)

Ryan Burke (JCPP/APhA)

Anne Burns (APhA)

Stephanie Callinan (ASCP)

MaryJo Carden (AMCP)

Adam Chesler (PTCB)

Addolorata Ciccone (ASCP)

Sharon Clackum (ASCP)

Arnold Clayman (ASCP)

Kevin Day (NCPA)

Lauren Fuller (AMCP)

Carolyn Ha (NCPA)

Sheldon Holstad (ACCP)

Sean Jeffery (ASCP)

Elizabeth Jex (FTC)

Ray Love (CPNP)

Stacie Maass (APhA)

Everett McAllister (PTCB)

Steve Mullinex (NCPDP)

Jim Owen (APhA)

Margaret Robinson (NASPA)

Mitchel Rothholz (JCPP/APhA)

Elizabeth “Scotti” Russell (NABP)

Doug Scheckelhoff (ASHP)

Lisa Schwartz (NCPA)

Todd Sega (AMCP)

Amy Shank (PCCA)

April Shaughnessy (AMCP)

Mindy Smith (APhA Foundation)

Todd Sorensen (AIMMc)

Ken Sprague (ASCP)

Lee Ann Stember (NCPDP)

Brian Wall (APhA Foundation /JCPP)

C. Edwin Webb (ACCP)

1

Member organizations of the Joint Commission of Pharmacy Practitioners (JCPP) held their regularly scheduled quarterly meeting on Thursday, August 21, 2014, at the Lorien Hotel, Alexandria, Virginia. Meeting participants were welcomed by Edith Rosato, AMCP CEO and Chair of this JCPP Meeting. Representatives of member organizations and guests introduced themselves.

Paul Abramowitz, ASHP CEO, provided a recognition and led a moment of silence regarding the recent passing of Janet Teeters, ASHP Director of Accreditation Services.

Opening Remarks / Administrative Activity

Members reviewed and accepted the Summary of Discussion from the May 29, 2014, JCPP meeting. The participants then reviewed the 2014 JCPP meeting schedule and template agendas. The meeting agenda for the November 19, 2014, JCPP meeting was accepted and the organizations were reminded that the registration memo was included in their meeting packets.

Update on Provider Status Activities - State Based Activities

Becky Snead, NASPA CEO, provided an overview of activity at the state level to achieve provider designation and service identification, payment and coverage for services, and optimization of pharmacy practice acts. She reviewed various state examples and the trends at the state level. The members discussed areas for collaboration to advance progress towards the JCPP Vision.

National Patient Safety and Clinical Pharmacy Services Collaborative

Todd Sorensen, PharmD, Executive Director of the Alliance for Integrated Medication Managrment Collaborative (AIMMc) discussed the work of AIMMc and the work conducted by participating practices that support the profession achieving a "tipping point" on delivery of medication management services and the alignment of AIMMc to JCPP's strategic goals.. He discussed with the JCPP organizations current status and direction of AIMMc and ways JCPP organizations can increase involvement with AIMMc.

Task Force Pharmacists' Role in Addressing Prescription Medication Misuse and Abuse

JCPP members reviewed the draft statement and principles on pharmacists' role in addressing prescription medication misuse and abuse prepared by a staff working group. This document is intended for use within and outside of the profession. After some discussion and suggested modifications, JCPP member organizations approved the draft as amended. The document is attached.

NCPDP Standards and Activities Related to Pharmacy Practice

Steve Mullinex, NCPDP Senior Vice President of Public Policy and Industry Relations, and Lee Ann Stember, NCPDP President, provided an overview of the history and membership of NCPDP, their role as a neutral convener, expansion in dentistry and NCPDP activities impacting pharmacy practice (compounding, ePrescribing, acetaminophen use and dosing, standardized dose designations, immunizations, medication synchronization, PDMP, prior authorization, audits and best practice initiatives).

JCPP Vision Strategic Plan

JCPP members reviewed a draft document prepared by the Strategic Planning Steering Committee. The CEOs were complimentary of the work conducted by the committee. A one-day planning meeting of JCPP member organization staff will be planned before the next meeting to refine the tactics contained within the plan related to the goals that JCPP will assume a leadership role and further discuss implementation of the plan. In addition, the CEOs will continue to discuss JCPP organizational structure to best implement the strategic plan within available resources. After discussion the JCPP members approved an amended version of the document goals and objectives.

Revisiting Competition Issues in the Follow-on Biologics Arena

Elizabeth Jex, attorney advisor at the Federal Trade Commission (FTC) discussed the work of the FTC regarding consumer protection in healthcare, particularly as it relates to pharmaceuticals and follow-on biologics. She reported that specialty drugs make up approximately 50% of drug spend. She reviewed current federal laws and barriers to the entry of lower cost products into the US market, including activity on the state level.

Hot Topics and Organizational Updates

No additional topic ideas for future JCPP meetings were identified at this time.

Each organization reported on progress it was making in the areas of focus related to the implementation of the JCPP Vision Strategic Plan: Patient Care Process; Pharmacy Quality; Value of Pharmacists’ Patient Care Services; HIT; Provider Status Recognition, in addition to other organizational information.

A number of newsletters, journals, and other educational materials from practitioner organizations were provided so that member organizations may better serve pharmacy practitioners and coordinate future projects.

The next regularly scheduled meeting of JCPP is November 19, 2014; it will focus on continued discussions around activity implementation related to the new vision statement, post-election impact on pharmacy’s agenda, accreditation of pharmacy practice, and data interchange.

There being no further business, the meeting was adjourned at 2:46pm.

###

1